These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30206136)
1. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors. Hagenbeek TJ; Webster JD; Kljavin NM; Chang MT; Pham T; Lee HJ; Klijn C; Cai AG; Totpal K; Ravishankar B; Yang N; Lee DH; Walsh KB; Hatzivassiliou G; de la Cruz CC; Gould SE; Wu X; Lee WP; Yang S; Zhang Z; Gu Q; Ji Q; Jackson EL; Lim DS; Dey A Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206136 [TBL] [Abstract][Full Text] [Related]
2. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
3. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458 [TBL] [Abstract][Full Text] [Related]
4. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor. Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450 [TBL] [Abstract][Full Text] [Related]
5. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation. Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the Hippo Pathway Transcription Factor TEAD. Lin KC; Park HW; Guan KL Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625 [TBL] [Abstract][Full Text] [Related]
7. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade. Budel SJ; Penning MM; Penning LC Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400 [TBL] [Abstract][Full Text] [Related]
8. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway. Miesfeld JB; Link BA Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909 [TBL] [Abstract][Full Text] [Related]
9. The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences. Hau JC; Erdmann D; Mesrouze Y; Furet P; Fontana P; Zimmermann C; Schmelzle T; Hofmann F; Chène P Chembiochem; 2013 Jul; 14(10):1218-25. PubMed ID: 23780915 [TBL] [Abstract][Full Text] [Related]
10. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005 [TBL] [Abstract][Full Text] [Related]
11. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides. Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421 [TBL] [Abstract][Full Text] [Related]
12. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.]. Ishihara E; Nishina H Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187 [TBL] [Abstract][Full Text] [Related]
13. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway. Chan P; Han X; Zheng B; DeRan M; Yu J; Jarugumilli GK; Deng H; Pan D; Luo X; Wu X Nat Chem Biol; 2016 Apr; 12(4):282-9. PubMed ID: 26900866 [TBL] [Abstract][Full Text] [Related]
17. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae. Rausch V; Bostrom JR; Park J; Bravo IR; Feng Y; Hay DC; Link BA; Hansen CG Curr Biol; 2019 Jan; 29(2):242-255.e6. PubMed ID: 30595521 [TBL] [Abstract][Full Text] [Related]
18. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Zhao B; Lei QY; Guan KL Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139 [TBL] [Abstract][Full Text] [Related]
19. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ. Lai D; Yang X Cell Signal; 2013 Aug; 25(8):1720-8. PubMed ID: 23673366 [TBL] [Abstract][Full Text] [Related]
20. The Hippo signaling pathway in liver regeneration and tumorigenesis. Hong L; Cai Y; Jiang M; Zhou D; Chen L Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]